Neurophet AQUA
Neurophet
Information source:
Vendor
Last updated: November 19, 2024 |
General Information
General | |
---|---|
Product name | Neurophet AQUA |
Company | Neurophet |
Subspeciality | Neuro |
Modality | MR |
Disease targeted | Mild cognitive impairment, Alzheimer's disease, dementia |
Key-features | Brain region segmentation, volume quantification, normative comparison, report generation, white matter hyperintensity quantification, multi-time-point analysis. |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps) |
Technical Specifications
Data characteristics | |
---|---|
Population | All brain MR |
Input | 3D T1 weighted image |
Input format | DICOM |
Output | Color-coded segmentation overlays, configurable reports with reference statistics, pre-populated radiological reporting template |
Output format | DICOM |
Technology | |
Integration | Integration in standard reading environment (PACS) |
Deployment | Locally on dedicated hardware |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | 1 - 10 minutes |
Regulatory
Certification | |
---|---|
CE |
Certified,
Class IIa
, MDD
|
FDA | 510(k) cleared , Class II |
Intended Use Statements | |
Intended use (according to CE) |
Market
Market presence | |
---|---|
On market since | 03-2020 |
Distribution channels | |
Countries present (clinical, non-research use) | 1 |
Paying clinical customers (institutes) | 15 |
Research/test users (institutes) | 50 |
Pricing | |
Pricing model | Subscription, One-off payment |
Based on | Pay-per-scan |
Evidence
Evidence | |
---|---|
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |